polymyxin b sulfate and trimethoprim sulfate

FDA Drug Profile — polymyxin b sulfate and trimethoprim sulfate

Drug Details

Generic Name
polymyxin b sulfate and trimethoprim sulfate
Brand Names
polymyxin b sulfate and trimethoprim sulfate
Application Number
ANDA211572
Sponsor
Somerset Therapeutics, LLC
NDC Codes
2
Dosage Forms
SOLUTION/ DROPS
Routes
OPHTHALMIC
Active Ingredients
POLYMYXIN B SULFATE, TRIMETHOPRIM

Indications and Usage

INDICATIONS AND USAGE Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution, USP is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus viridans, Haemophilus influenzae and Pseudomonas aeruginosa. * * Efficacy for this organism in this organ system was studied in fewer than 10 infections.

Warnings

WARNINGS NOT FOR INJECTION INTO THE EYE. If a sensitivity reaction to polymyxin B sulfate and trimethoprim ophthalmic solution occurs, discontinue use. Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution is not indicated for the prophylaxis or treatment of ophthalmia neonatorum.